Skip to main content
. 2021 Sep 6;71(7):1340–1349. doi: 10.1136/gutjnl-2021-324852

Figure 1.

Figure 1

Flowchart of study design and patient selection. ctDNA, circulating tumour DNA; mCRC, metastatic colorectal cancer; NED, no evidence of disease; WES, whole-exome sequencing.